YWYaxin Wang

Yaxin Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yaxin Wang has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Na/K-ATPase Signaling in Adipocytes Promotes Atherosclerosis

    by Bruno De Souza Goncalves, Yaxin Wang, Sneha S. Pillai, Quoc Quang Luu, Hortense Triniac, Hari Vishal Lakhani, Muhammad A. Chaudhry, Ze Zheng, Joseph I. Shapiro, Roy L. Silverstein, et al.

    BACKGROUND: Adipocyte dysfunction is closely associated with oxidative stress and chronic inflammation, which contribute to systemic metabolic disturbances and atherosclerosis. We previously identified the NKA (Na/K-ATPase) α1 subunit as a signal transducer that activates Src-family kinases and promotes oxidative stress and inflammation in various cell types, including adipocytes and macrophages. NaKtide, a peptide inhibitor of NKA signaling, has been shown to reduce systemic oxidative stress and inflammation in vivo. In this study, we investigated the role of adipocyte-specific NKA signaling in atherosclerosis. METHODS: Adipocyte-specific NaKtide was delivered to Apoe −/− mice using a lentiviral vector under the adiponectin promoter. The mice were then fed a Western diet for 12 weeks to induce atherosclerosis and then assessed for atherosclerotic plaque burden in the aortic arch and at the level of the aortic sinus. Inflammatory and oxidative stress markers were analyzed in adipose tissue and plasma. RESULTS: Adipocyte-specific NaKtide reduced atherosclerotic plaque area by 67% in the aortic arch and by 48% in the aortic sinus. CD68+ (cluster of differentiation 68) macrophage content and α-SMA+ (α-smooth muscle actin) smooth muscle cell content in the aortic sinus were decreased by 45% and 53%, respectively. These vascular improvements were accompanied by dampened adipose tissue inflammation and oxidative stress, improved glucose tolerance, and reduced systemic inflammation. CONCLUSIONS: These findings highlight a critical contributing role for adipocyte NKA signaling in atherosclerosis, suggesting an important endocrine and paracrine influence of adipose tissue on large artery atherogenesis and supporting the therapeutic potential of targeting NKA in cardiometabolic disease.

  • Macrophage PIM1 Drives Atherosclerosis by Enhancing Foam Cell Formation Via CD36

    by Mirza Ahmar Beg, Quoc Quang Luu, Vaya Chen, Yaxin Wang, Gang Xin, Weiguo Cui, Roy L. Silverstein, Yiliang Chen

    BACKGROUND: Atherosclerosis is characterized by the buildup of fatty plaques that thicken and stiffen arterial walls. Mφs (macrophages) significantly contribute to this process through their scavenger receptor CD36 (cluster of differentiation 36). PIM1 (proviral integration site for Moloney murine leukemia virus 1) is a serine/threonine kinase known to modulate immune responses and cell metabolism. However, its role in Mφ lipid handling and atherogenesis is not well defined. This study examines the role of PIM1 in regulating CD36 expression and function in Mφs during foam cell formation and atherosclerosis progression. METHODS: We performed in vitro studies by treating murine peritoneal Mφs from Pim1 −/− and wild-type mice with oxLDL (oxidized low-density lipoprotein). We measured CD36, PIM1, and plaque-associated proteins and mRNA levels, oxLDL binding and uptake rates, and foam cell formation. For in vivo studies, we fed myeloid-specific Pim1 -deficient ( Apoe −/− Lyz2 Cre/+ Pim1 fl/fl ) and their littermate control ( Apoe −/− Pim1 fl/fl ) mice a high-fat diet for 12 weeks. We then evaluated plaque formation in their aortic sinuses and arches. RESULTS: Deletion of Pim1 in Mφs reduced CD36 protein expression by up to 96.7% compared with wild-type controls. This led to a 49.6% decrease in foam cell formation and a 25.5% reduction in cellular cholesterol after oxLDL treatment. Pharmacological inhibition of PIM kinase activity in wild-type Mφs also impaired oxLDL handling, with a 64.5% reduction in binding and a 57.9% reduction in uptake. Bulk RNA-sequencing revealed that Pim1 deficiency downregulated PPARγ (peroxisome proliferator-activated receptor gamma) signaling. Treatment with a PPARγ agonist restored CD36 levels in the Pim1 knockdown Mφs, suggesting that PIM1 regulates CD36 through PPARγ. Moreover, Pim1 myeloid–specific deficiency caused a 69.4% reduction in atherosclerotic plaque formation. CONCLUSIONS: PIM1 acts as a key upstream regulator of CD36 by enhancing PPARγ activity in Mφs. The PIM1-CD36 axis promotes oxLDL binding, uptake, and foam cell formation. Targeting the PIM1/PPARγ/CD36 pathway could offer new ways to modulate Mφ lipid metabolism and reduce atherosclerotic plaque progression.


  • Open Access

    Protective Role of 4‐Octyl Itaconate in Murine LPS/D‐GalN‐Induced Acute Liver Failure via Inhibiting Inflammation, Oxidative Stress, and Apoptosis

    by Ruidong Li, Wenchang Yang, Yuping Yin, Peng Zhang, Yaxin Wang, Kaixiong Tao

    Oxidative stress, inflammation, and apoptosis are crucial in the pathogenesis of acute liver failure (ALF). 4‐Octyl itaconate (OI) showed antioxidative and anti‐inflammatory properties in many disease models. However, its role in lipopolysaccharide‐ (LPS‐)/D‐galactosamine‐ (D‐GalN‐) induced ALF is still not investigated. Here, we established an ALF murine model induced by LPS/D‐GalN administration. And we found that OI improved survival rate in the murine ALF model. Our results also showed that OI alleviated LPS/D‐GalN‐induced hepatic histopathological injury and reduced the serum activities of alanine transaminase and aspartate transaminase. Moreover, OI reduced serum levels of proinflammatory cytokines such as monocyte chemotactic protein‐1, tumor necrosis factors‐α, and interlukin‐6. Additionally, OI mitigated oxidative stress and alleviated lipid peroxidation in a murine model of ALF. This was evaluated by a reduction of thiobarbituric acid reactive substances (TBARS) in liver tissues. In addition, OI increased the ratio of reduced glutathione/oxidized glutathione and the activities of antioxidant enzymes including catalase and superoxide dismutase. Moreover, the apoptosis of hepatocytes in the liver was inhibited by OI. Furthermore, we found that OI inhibited LPS‐induced nuclear translocation and activation of factor‐kappa B (NF‐κB) p65 in macrophages which could be inhibited by OI‐induced activation of nuclear factor erythroid‐2‐related factor (Nrf2) signaling. Additionally, D‐GalN‐induced reactive oxygen species (ROS) generation and apoptosis in hepatocytes were inhibited by OI‐induced activation of Nrf2 signaling. Therefore, the underlying mechanism for OI’s protective effect in LPS/D‐GalN‐induced ALF may be associated with deactivation of NF‐κB signaling in macrophages to reduce inflammation and inhibition of ROS‐related hepatocyte apoptosis by activating Nrf2. In conclusion, OI showed a protective role in LPS/D‐GalN‐induced ALF by reducing inflammation, enhancing antioxidant capacity, and inhibiting cell apoptosis.


  • Open Access

    Imaging Mass Cytometric Analysis of Postmortem Tissues Reveals Dysregulated Immune Cell and Cytokine Responses in Multiple Organs of COVID-19 Patients

    by Chong Wang, Jiqian Xu, Shaoyuan Wang, Shangwen Pan, Jiancheng Zhang, Yang Han, Muhan Huang, Di Wu, Qingyu Yang, Xiaobo Yang, et al.

    SARS-coronavirus-2–induced immune dysregulation and inflammatory responses are involved in the pathogenesis of coronavirus disease-2019 (COVID-19). However, very little is known about immune cell and cytokine alterations in specific organs of COVID-19 patients. Here, we evaluated immune cells and cytokines in postmortem tissues, i.e., lungs, intestine, liver, kidneys, and spleen of three patients with COVID-19. Imaging mass cytometry revealed monocyte, macrophage, and dendritic cell (DC) infiltration in the lung, intestine, kidney, and liver tissues. Moreover, in patients with COVID-19, natural killer T cells infiltrated the liver, lungs, and intestine, whereas B cells infiltrated the kidneys, lungs, and intestine. CD11b+ macrophages and CD11c+ DCs also infiltrated the lungs and intestine, a phenomenon that was accompanied by overproduction of the immunosuppressive cytokine interleukin (IL)-10. However, CD11b+ macrophages and CD11c+ DCs in the lungs or intestine of COVID-19 patients did not express human leukocyte antigen DR isotype. In contrast, tumor necrosis factor (TNF)-α expression was higher in the lungs, intestine, liver, and kidneys, but not in the spleen, of all COVID-19 patients (compared to levels in controls). Collectively, these findings suggested that IL-10 and TNF-α as immunosuppressive and pro-inflammatory agents, respectively,—might be prognostic and could serve as therapeutic targets for COVID-19.


  • Open Access

    Itaconate: A Metabolite Regulates Inflammation Response and Oxidative Stress

    by Ruidong Li, Peng Zhang, Yaxin Wang, Kaixong Tao

    Metabolic products can lead to crucial biological function alterations. Itaconate is probably the best example of how a metabolic process can be diverted to generate an immunomodulator effect in macrophages. Through inflammatory stimuli, such as lipopolysaccharide, the immune response gene 1 is activated and promotes the production of itaconate from the tricarboxylic acid cycle by decarboxylating cis-aconitate. Itaconate has been reported to have multiple immunoregulatory and antioxidative effects. In addition, reports have described its antibacterial and protumor effects. The involved mechanism in these effects includes the activation of nuclear factor E2-related factor 2 by alkylation of Kelch-like ECH-associated protein 1, inhibition of aerobic glycolysis by targeting glyceraldehyde-3-phosphate dehydrogenase and fructose-bisphosphate aldolase A, inhibition of succinate dehydrogenase, and blockade of IκBζ translation. All of these discoveries elucidated the transformation of the pro- into anti-inflammatory status in macrophages, which is crucial in innate immunity and set the ground for the emerging therapeutic implications of itaconate. In this review, we point out that itaconate is a novel and pivotal metabolic determinant of the immunoregulatory response in macrophages and highlight studies that have improved our understanding of the connection between the immune response and metabolism. In addition, we shed light on the therapeutic potential of itaconate and its derivatives to treat inflammatory diseases.